SECsense Logo

Omega Therapeutics, Inc. 8-K Report: Key Updates for Investors (January 10, 2025)

$OMGA
Form 8-K
Filed on: 2025-01-10
Source
Omega Therapeutics, Inc. 8-K Report: Key Updates for Investors (January 10, 2025)

Based on the provided XML section of the financial report, here are the key insights extracted:

  1. Filing Information:
  • Form Type: 8-K
  • Filing Date: January 10, 2025
  • CIK Number: 0001850838 (Central Index Key used by the SEC for company identification)
  1. Company Overview:
  • Company Name: Omega Therapeutics, Inc.
  • State of Incorporation: Delaware (DE)
  • SEC Central Index Key (CIK): 0001850838
  • IRS Employer Identification Number (EIN): 81-3247585
  • Address: 140 First Street, Suite 501, Cambridge, MA 02141
  • Contact Number: (617) 949-4360
  1. Stock Information:
  • Common Stock: Par value of $0.001 per share
  • Ticker Symbol: OMGA
  • Exchange: NASDAQ
  1. Reporting Period:
  • Period Covered: The report is for a single day, January 10, 2025.

Insights:

  • The filing is an 8-K report, which typically indicates significant events that shareholders should be aware of, such as mergers, acquisitions, or other material events.
  • The company is listed on NASDAQ under the ticker symbol OMGA, which could interest investors looking at biotech or therapeutic stocks.
  • The concise nature of the reporting period (one day) might suggest a specific event or announcement rather than a comprehensive quarterly or annual report.

Conclusion:

This report likely contains important updates related to Omega Therapeutics, Inc. that warrant shareholder attention. Further details within the 8-K filing would be needed to understand the specifics of the events or changes being reported.